 AAA in asymptomatic
men older than 65 years has been shown to be costeffective in the United Kingdom261 and through Markov
modeling.770 In the United Kingdom, the cost per lifeyear saved with screening was $1173, which is less costly
than screening programs for breast, cervical, and colorectal cancer.771 The cost-effectiveness of screening for
younger cohorts, women, and reimaging intervals for
small